BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8048150)

  • 1. Synthesis and biological testing of 4'-(dimethylamino)-17 beta-hydroxy-17 alpha-(1-propynyl)benzo[12,12a]-11 alpha,18-cyclo-12a,12b-dihomo-13 alpha-estr-4-en-3-one: an interesting RU 38 486 analog.
    Ottow E; Beier S; Elger W; Fritzemeier KH; Neef G; Wiechert R
    Steroids; 1994 Mar; 59(3):185-9. PubMed ID: 8048150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New analogues of mifepristone with more dissociated antiprogesterone activities.
    Philibert D; Hardy M; Gaillard-Moguilewsky M; Nique F; Tournemine C; Nédélec L
    J Steroid Biochem; 1989; 34(1-6):413-7. PubMed ID: 2560520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 11beta-(4-dimethylaminophenyl)-17beta-hydroxy-17alpha- (3-methyl-1-butynyl)-4, 9-estradien-3-one and 11beta-(4-acetophenyl)- 17beta-hydroxy-17alpha-(3-methyl-1-butynyl)-4, 9-estradien-3-one: two new analogs of mifepristone (RU-486).
    Hazra BG; Basu S; Pore VS; Joshi PL; Pal D; Chakrabarti P
    Steroids; 2000 Mar; 65(3):157-62. PubMed ID: 10699595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a fluorescent steroid derivative with high affinities for the glucocorticoid and progesterone receptors.
    Teutsch G; Klich M; Bouchoux F; Cerede E; Philibert D
    Steroids; 1994 Jan; 59(1):22-6. PubMed ID: 8140598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of D-ring substituents on antiprogestational (antagonist) and progestational (agonist) activity of 11 beta-aryl steroids.
    Cook CE; Lee YW; Wani MC; Fail PA; Petrow V
    Hum Reprod; 1994 Jun; 9 Suppl 1():32-9. PubMed ID: 7962467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of activity profile in analogs of the antiprogestin RU 486: effect of a 16 alpha-substituent on progestational (agonist) activity.
    Cook CE; Wani MC; Lee YW; Fail PA; Petrow V
    Life Sci; 1993; 52(2):155-62. PubMed ID: 8355555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses and antigestagenic activity of mifepristone derivatives.
    Hödl C; Raunegger K; Strommer R; Ecker GF; Kunert O; Sturm S; Seger C; Haslinger E; Steiner R; Strauss WS; Schramm HW
    J Med Chem; 2009 Mar; 52(5):1268-74. PubMed ID: 19216549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigestogens.
    Baird DT
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestin and antiprogestin effects on progesterone receptor transformation.
    Spilman CH; Gibson RE; Beuving DC; Campbell JA
    J Steroid Biochem; 1986 Jan; 24(1):383-9. PubMed ID: 2939296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interruption of early pregnancy by an anti-progestational compound, RU 486.
    Haspels AA
    Eur J Obstet Gynecol Reprod Biol; 1985 Sep; 20(3):169-75. PubMed ID: 4054413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of R5020 and RU486 binding to progesterone receptor from calf uterus.
    Hurd C; Moudgil VK
    Biochemistry; 1988 May; 27(10):3618-23. PubMed ID: 3408715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sex hormone receptors, prostaglandins and cAMP, in functional activity of the uterus].
    Zaĭtseva TS; Morozova MS; Goncharova VN; Asribekova MK; Karpova SK; Astakhova TM; Murashko LE
    Vestn Ross Akad Med Nauk; 1994; (12):13-6. PubMed ID: 7742650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RU 486.
    Ulmann A; Teutsch G; Philibert D
    Sci Am; 1990 Jun; 262(6):42-8. PubMed ID: 2343294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiprogestins].
    Göretzlehner G; Köhler G
    Zentralbl Gynakol; 1988; 110(12):766-71. PubMed ID: 3063028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 11 beta,13 beta- and 13 beta,16 beta-propano steroids: probes of hormonal activity.
    Pitt CG; Rector DH; Cook CE; Wani MC
    J Med Chem; 1979 Aug; 22(8):966-70. PubMed ID: 226703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant: a new role for RU-486 and related compounds.
    Parthasarathy S; Morales AJ; Murphy AA
    J Clin Invest; 1994 Nov; 94(5):1990-5. PubMed ID: 7962545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid antagonists and receptor-associated proteins.
    Lebeau MC; Baulieu EE
    Hum Reprod; 1994 Mar; 9(3):437-44. PubMed ID: 8006131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of uterine contractility by progesterone and progesterone metabolites: mediation by progesterone and gamma amino butyric acidA receptor systems.
    Putnam CD; Brann DW; Kolbeck RC; Mahesh VB
    Biol Reprod; 1991 Aug; 45(2):266-72. PubMed ID: 1664743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium- and rhenium-labeled progestins: synthesis, receptor binding and in vivo distribution of an 11 beta-substituted progestin labeled with technetium-99 and rhenium-186.
    DiZio JP; Anderson CJ; Davison A; Ehrhardt GJ; Carlson KE; Welch MJ; Katzenellenbogen JA
    J Nucl Med; 1992 Apr; 33(4):558-69. PubMed ID: 1552341
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.